IRIS Accounts Production v26.1.10.61 14595125 Board of Directors 1.2.25 31.1.26 31.1.26 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh145951252025-01-31145951252026-01-31145951252025-02-012026-01-31145951252024-01-31145951252024-02-012025-01-31145951252025-01-3114595125ns15:EnglandWales2025-02-012026-01-3114595125ns14:PoundSterling2025-02-012026-01-3114595125ns10:Director12025-02-012026-01-3114595125ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3114595125ns10:SmallEntities2025-02-012026-01-3114595125ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3114595125ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3114595125ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3114595125ns10:FullAccounts2025-02-012026-01-3114595125ns10:OrdinaryShareClass12025-02-012026-01-3114595125ns5:CurrentFinancialInstruments2026-01-3114595125ns5:CurrentFinancialInstruments2025-01-3114595125ns5:Non-currentFinancialInstruments2026-01-3114595125ns5:Non-currentFinancialInstruments2025-01-3114595125ns5:ShareCapital2026-01-3114595125ns5:ShareCapital2025-01-3114595125ns5:RetainedEarningsAccumulatedLosses2026-01-3114595125ns5:RetainedEarningsAccumulatedLosses2025-01-3114595125ns10:RegisteredOffice2025-02-012026-01-3114595125ns5:MotorVehicles2025-02-012026-01-3114595125ns5:ComputerEquipment2025-02-012026-01-3114595125ns5:MotorVehicles2025-01-3114595125ns5:ComputerEquipment2025-01-3114595125ns5:MotorVehicles2026-01-3114595125ns5:ComputerEquipment2026-01-3114595125ns5:MotorVehicles2025-01-3114595125ns5:ComputerEquipment2025-01-3114595125ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-01-3114595125ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-02-012026-01-3114595125ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2026-01-3114595125ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-01-3114595125ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3114595125ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3114595125ns5:AcceleratedTaxDepreciationDeferredTax2026-01-3114595125ns5:AcceleratedTaxDepreciationDeferredTax2025-01-3114595125ns5:DeferredTaxation2025-01-3114595125ns5:DeferredTaxation2025-02-012026-01-3114595125ns5:DeferredTaxation2026-01-3114595125ns10:OrdinaryShareClass12026-01-31
REGISTERED NUMBER: 14595125 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 JANUARY 2026

FOR

COTSWOLD FOOT AND ANKLE SURGERY LIMITED

COTSWOLD FOOT AND ANKLE SURGERY LIMITED (REGISTERED NUMBER: 14595125)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026










Page

Balance Sheet 1

Notes to the Financial Statements 3


COTSWOLD FOOT AND ANKLE SURGERY LIMITED (REGISTERED NUMBER: 14595125)

BALANCE SHEET
31 JANUARY 2026

2026 2025
Notes £ £ £ £
FIXED ASSETS
Tangible assets 5 50,073 34,253

CURRENT ASSETS
Debtors 6 7,824 11,167
Cash at bank 149,532 87,538
157,356 98,705
CREDITORS
Amounts falling due within one year 7 27,496 22,600
NET CURRENT ASSETS 129,860 76,105
TOTAL ASSETS LESS CURRENT
LIABILITIES

179,933

110,358

CREDITORS
Amounts falling due after more than one
year

8

(43,894

)

(29,788

)

PROVISIONS FOR LIABILITIES 9 (12,518 ) (6,508 )
NET ASSETS 123,521 74,062

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 123,421 73,962
SHAREHOLDERS' FUNDS 123,521 74,062

COTSWOLD FOOT AND ANKLE SURGERY LIMITED (REGISTERED NUMBER: 14595125)

BALANCE SHEET - continued
31 JANUARY 2026


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 June 2026 and were signed on its behalf by:





Mr N J O Hutt - Director


COTSWOLD FOOT AND ANKLE SURGERY LIMITED (REGISTERED NUMBER: 14595125)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026


1. STATUTORY INFORMATION

Cotswold Foot and Ankle Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 14595125

Registered office: 48 St Leonards Road
Bexhill on Sea
East Sussex
TN40 1JB

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
The turnover shown in the profit and loss account represents amounts receivable for services provided during the year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

All fixed assets are initially recorded at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


COTSWOLD FOOT AND ANKLE SURGERY LIMITED (REGISTERED NUMBER: 14595125)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026


3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

COTSWOLD FOOT AND ANKLE SURGERY LIMITED (REGISTERED NUMBER: 14595125)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026


5. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£ £ £
COST
At 1 February 2025 43,903 2,517 46,420
Additions 32,279 1,004 33,283
At 31 January 2026 76,182 3,521 79,703
DEPRECIATION
At 1 February 2025 10,976 1,191 12,167
Charge for year 16,301 1,162 17,463
At 31 January 2026 27,277 2,353 29,630
NET BOOK VALUE
At 31 January 2026 48,905 1,168 50,073
At 31 January 2025 32,927 1,326 34,253

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£
COST
At 1 February 2025 43,903
Additions 32,279
At 31 January 2026 76,182
DEPRECIATION
At 1 February 2025 10,976
Charge for year 16,301
At 31 January 2026 27,277
NET BOOK VALUE
At 31 January 2026 48,905
At 31 January 2025 32,927

COTSWOLD FOOT AND ANKLE SURGERY LIMITED (REGISTERED NUMBER: 14595125)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£ £
Trade debtors 3,381 7,263
Other debtors 400 700
Prepayments and accrued income 4,043 3,204
7,824 11,167

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£ £
Hire purchase contracts 5,367 5,101
Corporation tax 9,622 5,178
Directors' current accounts 2,082 1,584
Accruals and deferred income 10,425 10,737
27,496 22,600

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2026 2025
£ £
Hire purchase contracts 43,894 29,788

9. PROVISIONS FOR LIABILITIES
2026 2025
£ £
Deferred tax
Accelerated capital allowances 12,518 6,508

Deferred tax
£
Balance at 1 February 2025 6,508
Charge to Profit and Loss Account during year 6,010
Balance at 31 January 2026 12,518

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £ £
100 Ordinary £1 100 100